申请人:Revolution Medicines, Inc.
公开号:US20220396589A1
公开(公告)日:2022-12-15
The invention features macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capable of inhibiting Ras proteins, and their uses in the treatment of cancers.